Aarey Drugs

{
  "main_header": {
    "sid": 933527,
    "name": "Aarey Drugs",
    "stock_name": "Aarey Drugs",
    "full_name": "Aarey Drugs & Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/aarey-drugs",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "92.00",
    "chg": 4.25,
    "chgp": "4.84%",
    "dir": 1,
    "prev_price": "87.75",
    "mcapval": "252.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524412,
    "symbol": "AAREYDRUGS",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 49,
    "indexname": "India SENSEX",
    "isin": "INE198H01019",
    "curr_date": "May 08",
    "curr_time": "",
    "bse_nse_vol": "3.0 lacs",
    "exc_status": "Active",
    "traded_date": "May 08, 2026",
    "traded_date_str": "2026 05 08",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/aarey-drugs-933527-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Aarey Drugs & Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/aarey-drugs-pharmaceuticals-ltd-is-rated-strong-sell-3982727",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AareyDrugsPharm_mojoScore_3982727.png",
        "date": "2026-05-09 10:10:36",
        "description": "Aarey Drugs & Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 28 Nov 2025, reflecting a change from a previous 'Sell' rating. However, all fundamentals, returns, and financial metrics discussed here are current as of 09 May 2026, providing an up-to-date view of the stock's position in the market."
      },
      {
        "title": "Aarey Drugs & Pharmaceuticals Ltd Locks at Lower Circuit With 4.98% Loss — Sellers Queue, No Buyers in Sight",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarey-drugs-pharmaceuticals-ltd-hits-lower-circuit-amid-heavy-selling-pressure-3969802",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AareyDrugsPharm_stocks_hitting_lower_circuit_3969802.png",
        "date": "2026-04-30 10:00:15",
        "description": "At Rs 86.00, sellers were still queuing — but there were no buyers willing to take the other side. Aarey Drugs & Pharmaceuticals Ltd locked at its lower circuit of 4.98% on 30 Apr 2026, with unfilled sell orders and a frozen price."
      },
      {
        "title": "Aarey Drugs & Pharmaceuticals Ltd Locks at Lower Circuit With 4.29% Loss — Sellers Queue, No Buyers in Sight",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarey-drugs-pharmaceuticals-ltd-hits-lower-circuit-amid-heavy-selling-pressure-3968489",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AareyDrugsPharm_stocks_hitting_lower_circuit_3968489.png",
        "date": "2026-04-29 15:00:07",
        "description": "At Rs 91.11, Aarey Drugs & Pharmaceuticals Ltd locked at its lower circuit on 29 Apr 2026, reflecting a 4.29% decline within a 5% price band. Sellers were lined up to exit, but buyers were absent, resulting in unfilled supply and a frozen price that underscores the liquidity challenges faced by this micro-cap stock."
      },
      {
        "title": "Aarey Drugs & Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/aarey-drugs-pharmaceuticals-ltd-is-rated-strong-sell-3966316",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AareyDrugsPharm_mojoScore_3966316.png",
        "date": "2026-04-28 10:10:55",
        "description": "Aarey Drugs & Pharmaceuticals Ltd is rated 'Strong Sell' by MarketsMOJO, with this rating last updated on 28 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 April 2026, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Aarey Drugs Gains 7.40% Despite Volatility: 4 Key Factors Driving the Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarey-drugs-gains-740-despite-volatility-4-key-factors-driving-the-week-3962502",
        "imagepath": "",
        "date": "2026-04-25 14:03:33",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>20 Apr:</strong> Upper circuit hit at Rs.84.65 on strong buying pressure</p>\n                    <p><strong>21 Apr:</strong> Continued gains with Rs.88.04 close (+4.00%)</p>\n                    <p><strong>22 Apr:</strong> Price correction to Rs.85.99 (-2.33%) amid profit booking</p>\n                    <p><strong>23 Apr:</strong> Sharp rebound to Rs.89.91 (+4.56%) despite Sensex decline</p>\n                    <p><strong>24 Apr:</strong> Lower circuit hit at Rs.85.39 amid heavy selling</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.82.15</div></div>\n   ..."
      },
      {
        "title": "Aarey Drugs & Pharmaceuticals Ltd Locks at Lower Circuit With 5.0% Loss — Sellers Queue, No Buyers in Sight",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarey-drugs-pharmaceuticals-ltd-hits-lower-circuit-amid-heavy-selling-pressure-3961067",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AareyDrugsPharm_stocks_hitting_lower_circuit_3961067.png",
        "date": "2026-04-24 14:00:07",
        "description": "At Rs 85.39, sellers were still queuing — but there were no buyers willing to take the other side. Aarey Drugs & Pharmaceuticals Ltd locked at its lower circuit of 5.0% on 24 Apr 2026, with unfilled sell orders and a frozen price."
      },
      {
        "title": "Aarey Drugs & Pharmaceuticals Ltd Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarey-drugs-pharmaceuticals-ltd-hits-upper-circuit-amid-robust-buying-pressure-3954134",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AareyDrugsPharm_stocks_hitting_upper_circuit_3954134.png",
        "date": "2026-04-20 15:00:07",
        "description": "At Rs 85.13, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Aarey Drugs & Pharmaceuticals Ltd locked at its upper circuit of 5% on 20 Apr 2026, with buyers queuing and no sellers willing to part with shares."
      },
      {
        "title": "Aarey Drugs & Pharmaceuticals Ltd Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarey-drugs-pharmaceuticals-ltd-hits-upper-circuit-amid-strong-buying-momentum-3951092",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AareyDrugsPharm_stocks_hitting_upper_circuit_3951092.png",
        "date": "2026-04-17 15:00:07",
        "description": "At Rs 81.85, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Aarey Drugs & Pharmaceuticals Ltd locked at its upper circuit of 5% on 16 Apr 2026, with buyers queuing and no sellers willing to part with shares."
      },
      {
        "title": "Aarey Drugs & Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/aarey-drugs-pharmaceuticals-ltd-is-rated-strong-sell-3950620",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AareyDrugsPharm_mojoScore_3950620.png",
        "date": "2026-04-17 10:10:58",
        "description": "Aarey Drugs & Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 17 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook."
      }
    ],
    "total": 587,
    "sid": "933527",
    "stock_news_url": "https://www.marketsmojo.com/news/aarey-drugs-pharmaceuticals-933527"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "14-Apr-2026",
      "details": "Certificate under Reg 74(5) of SEBI (Depositories and Participants) Regulations 2018",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "26-Mar-2026",
      "details": "Intimation for closure of trading window",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "14-Feb-2026",
      "details": "Newspaper Publication of the Unaudited Financial Results",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Aarey Drugs & Pharmaceuticals Ltd has declared <strong>1%</strong> dividend, ex-date: 13 Dec 18",
          "dt": "2018-12-13",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Aarey Drugs & Pharmaceuticals Ltd has announced <strong>1:5</strong> bonus issue, ex-date: 25 Jun 12",
          "dt": "2012-06-25",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Aarey Drugs & Pharmaceuticals Ltd has announced <strong>2:1</strong> rights issue, ex-date: 19 Jan 12",
          "dt": "2012-01-19",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Aarey Drugs & Pharmaceuticals Ltd is Rated Strong Sell

2026-05-09 10:10:36

Aarey Drugs & Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 28 Nov 2025, reflecting a change from a previous 'Sell' rating. However, all fundamentals, returns, and financial metrics discussed here are current as of 09 May 2026, providing an up-to-date view of the stock's position in the market.

Read full news article

Aarey Drugs & Pharmaceuticals Ltd Locks at Lower Circuit With 4.98% Loss — Sellers Queue, No Buyers in Sight

2026-04-30 10:00:15

At Rs 86.00, sellers were still queuing — but there were no buyers willing to take the other side. Aarey Drugs & Pharmaceuticals Ltd locked at its lower circuit of 4.98% on 30 Apr 2026, with unfilled sell orders and a frozen price.

Read full news article

Aarey Drugs & Pharmaceuticals Ltd Locks at Lower Circuit With 4.29% Loss — Sellers Queue, No Buyers in Sight

2026-04-29 15:00:07

At Rs 91.11, Aarey Drugs & Pharmaceuticals Ltd locked at its lower circuit on 29 Apr 2026, reflecting a 4.29% decline within a 5% price band. Sellers were lined up to exit, but buyers were absent, resulting in unfilled supply and a frozen price that underscores the liquidity challenges faced by this micro-cap stock.

Read full news article

Aarey Drugs & Pharmaceuticals Ltd is Rated Strong Sell

2026-04-28 10:10:55

Aarey Drugs & Pharmaceuticals Ltd is rated 'Strong Sell' by MarketsMOJO, with this rating last updated on 28 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 April 2026, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Aarey Drugs Gains 7.40% Despite Volatility: 4 Key Factors Driving the Week

2026-04-25 14:03:33

Key Events This Week

20 Apr: Upper circuit hit at Rs.84.65 on strong buying pressure

21 Apr: Continued gains with Rs.88.04 close (+4.00%)

22 Apr: Price correction to Rs.85.99 (-2.33%) amid profit booking

23 Apr: Sharp rebound to Rs.89.91 (+4.56%) despite Sensex decline

24 Apr: Lower circuit hit at Rs.85.39 amid heavy selling

Week Open

Rs.82.15

...

Read full news article

Aarey Drugs & Pharmaceuticals Ltd Locks at Lower Circuit With 5.0% Loss — Sellers Queue, No Buyers in Sight

2026-04-24 14:00:07

At Rs 85.39, sellers were still queuing — but there were no buyers willing to take the other side. Aarey Drugs & Pharmaceuticals Ltd locked at its lower circuit of 5.0% on 24 Apr 2026, with unfilled sell orders and a frozen price.

Read full news article

Aarey Drugs & Pharmaceuticals Ltd Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent

2026-04-20 15:00:07

At Rs 85.13, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Aarey Drugs & Pharmaceuticals Ltd locked at its upper circuit of 5% on 20 Apr 2026, with buyers queuing and no sellers willing to part with shares.

Read full news article

Aarey Drugs & Pharmaceuticals Ltd Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent

2026-04-17 15:00:07

At Rs 81.85, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Aarey Drugs & Pharmaceuticals Ltd locked at its upper circuit of 5% on 16 Apr 2026, with buyers queuing and no sellers willing to part with shares.

Read full news article

Aarey Drugs & Pharmaceuticals Ltd is Rated Strong Sell

2026-04-17 10:10:58

Aarey Drugs & Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 17 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.

Read full news article

View All News